explore -WSS

explore

author：leisure time 2025-09-06 05:03:18 - browse：5

Mini people figurines stand in line beside a stethoscope. -- health business coverage from STAT — Adobe

It’s the middle of October — the time of year that’s filled with pumpkin spice lattes, jumbo-sized bags of Halloween candy, and endless advertisements to sign up for Medicare.

Medicare’s annual enrollment period kicked off Sunday and runs through Dec. 7, allowing eligible older adults and people with disabilities to sign up for traditional Medicare coverage or Medicare Advantage, the alternative option that is run by health insurance companies.

A lot is changing during this year’s enrollment window. The federal government is cracking down on deceptive TV ads and other messaging that exaggerate the benefits of, or hide the potential flaws of, Medicare Advantage plans. The Senate Finance Committee is holding a hearing this week on that same topic. Prescription drug plan premiums also are fluctuating a lot in many areas in response to provisions embedded in the Inflation Reduction Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： How the messy conversation about Dolly changed bioethics

WSS

How the first Native Hawaiian psychiatrist helped diversify medicine

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Vivek Ramaswamy made waves in the debate, much as in biotech

House panel takes first step toward fixing drug shortages

David Liu startup to focus on CRISPR delivery

Free Covid tests will again be offered to all U.S. households

explore

explore

hotspot

Supreme Court strikes down use of affirmative action

FDA greenlights medical device to combat bladder issues

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Trans patients at the end of life deserve respect and dignity

Heart attack and stroke risk calculators need revising

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Cancer drug shortages should be causing more outrage

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

After affirmative action ruling, medical educators look to 'holistic review'

Roche's accidental data boosts hopes for anti

focus

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Grad students accuse University of California of wage theft

Can U.S. cancer drug shortages be fixed?

FDA advisory panel to debate high blood pressure devices

Republicans love RFK Jr. What's that tell us about health in 2024?

Wegovy improves function in certain heart failure patients

explore

explore

focus

hotspot